After

Revolutionizing Tourism with Web3: A Landmark Partnership Between Camino Network, DCM Swiss, 1World Online, and Web3-Solutions

In an unprecedented-opportunity-driven move, four innovative companies in the travel and marketing sectors — Camino Network, initiated by Chain4Travel, DCM Swiss, 1World Online, and Web3-Solutions — have come together to announce a landmark partnership. This alliance aims to harness cutting-edge technologies in reshaping the future of travel and tourism experiences and bringing new monetization options and benefits to all ecosystem participants. We are happy to announce that: DCM Swiss and 1World Online are becoming Validators at Camino Network. Web3-Solutions becomes a Regional Partner of DCM: A regional partnership agreement has

K10 Esports Embarks on a Revolutionary Journey: From Championships to the TCG World Metaverse.

An Exciting New Frontier for Esports Fans and Gamers Alike London, England. October 6, 2023. In a groundbreaking move that promises to redefine the esports landscape, the globally-renowned K10 Esports announces its next venture: diving into the world of the Metaverse with TCG World. As they continue their relentless pursuit of glory in games such as CS2, Valorant, and many more titles to come, K10 is now set to offer fans an unprecedented immersive experience by streaming their matches live in virtual venues within the TCG World Metaverse. This pioneering

Zumo first to launch platform built to meet the tech requirements of the FCA’s new Financial Promotions Regime for Crypto Assets

  The award-winning platform has set a new benchmark in consumer protection and regulatory alignment With some UK operators having to pause activity, Zumo’s financial promotions technical flow is now also available through its B2B API to support unregistered firms with remaining compliant after the 8 October deadline [London/Edinburgh - Friday 29 September 2023] Zumo, the UK-based digital-asset-as-a-service platform, has announced a significant industry milestone as it becomes the first digital asset platform to have integrated tech based requirements of the Financial Conduct Authority’s (FCA’s) new financial promotions regime for

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

Welcome Renal Warriors

I am a 68 year old man born in Brooklyn, New York and living for decades in Ithaca, NY. I also have 10 years each with homes in @San Ramon, Costa Rica and @Austin, Texas. My present and future dreams are in #Africa and I am setting up a base in @CapeTown, South Africa. #notmytimetodie #supportmymiracle #childofimmigrants #latebloomer. I was told a year ago that I would certainly die if I did not have not follow the standard treatment of care. I rejected both dialysis and a transplant and am

American Picture House Corporate Update

New York, NY, Raleigh, NC, and Los Angeles, CA.  September 6, 2023 – American Picture House Corporation (OTC: APHP), an entertainment company with a focus on producing feature films, limited series, and entertainment enhancing technologies, today provided a corporate update for shareholders. Industry Strikes American Picture House supports the ideals behind the two current industry strikes -- brought by the Writers Guild of America (“WGA”) and the Screen Actors Guild (“SAG”) -- and joins the many reasonable voices urging for a fair and timely resolution. Update on Feature Films -

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

BREATHE! Convention Charts New Territory with World’s Largest Communal NFT

For Immediate Release June 19, 2023 LAS VEGAS, NV - BREATHE! Convention, a leading event in the emerging tech space, proudly announces a groundbreaking endeavor to set a new Guinness World Record with the creation of the World’s Largest Communal NFT, during its upcoming convention in Las Vegas from September 13 to 15, 2023. At the heart of this year's convention is a monumental collaborative art project spearheaded by tech industry veteran and creative thinker, Aaron Vick. Known for his innovative digital art pieces, Aaron Vick will facilitate the creation

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

SaaS Inclusology Releases New 2.0 Platform and Proves to Help Companies Achieve DEI (Diversity, Equity, and Inclusion) Goals in Accelerated Timeline.

June 2023 - Inclusology, is a powerful all in one DEI management SaaS platform designed to help companies reduce bias in the workplace and increase employee retention. Last week, the platform released its new version after completing beta testing among 16 companies and thousands of employees across startups, nonprofits, Fortune 500 and 1000 companies etc. “We are so proud to see Inclusology’s work having a positive impact on DEI at a global level in every sized company,” says CEO Dr. Cheryl Ingram. “We’ve tested our software in a number of

Paribus Vision

For those who missed our announcements on social media, we are thrilled to share the exciting news that our Mainnet v1 will be relaunched on May 31st! The past few weeks have been demanding and challenging, but we couldn’t be happier with our progress. At Paribus, we have always emphasized the importance of security. While we were shocked and saddened by the exploitation of a loophole in our code, we firmly believe in finding the silver lining in every cloud. The steps we’ve taken following this unfortunate incident have made

Rocket Raccoon: A Phenomenon of Memecoin Magic and the Pursuit of Financial Liberation

In the ever-evolving world of cryptocurrencies, a remarkable phenomenon has captured the imagination of both seasoned investors and enthusiasts alike. This captivating tale revolves around the rise of a viral memecoin, where a charismatic raccoon character named Rocket has taken centre stage. Welcome to the intriguing world of Degen RocketRacoon. Drawing inspiration from the Marvel Cinematic Universe, particularly the beloved Guardians of the Galaxy franchise, Degen RocketRacoon seeks to deliver an electrifying rush that crypto investors crave. Despite its stealthy launch, this audacious project has swiftly captured public attention, boasting